Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
Regulatory & Industry
All Research Areas
News
Discovery Insider
Content
Content
Webinars
eBooks
Infographics
Videos
Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
Magazine
All Content
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
Regulatory & Industry
All Research Areas
News
Discovery Insider
Content
Content
Webinars
eBooks
Infographics
Videos
Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
Magazine
All Content
Subscribe!
Subscribe Today!
Home
/
Jim Cirigliano
Jim Cirigliano
This person does not yet have a bio.
Articles by Jim Cirigliano
| 3 min read
By
Jim Cirigliano
Preparing to launch personalized medicine
Air Force longitudinal study aims to prepare healthcare providers for a world rife with personal genomic information
Articles
| 3 min read
By
Jim Cirigliano
PROOF, MRM Proteomics turn the peptides
Protein signatures could become companion diagnostics to optimize drug discovery and patient care management
Articles
| 3 min read
By
Jim Cirigliano
A window into VISTA
Partnership aims to develop immunotherapies for cancer based on new negative checkpoint regulator
Articles
| 3 min read
By
Jim Cirigliano
Adding mixtures to the mix
Merck, Symphogen ink $600 million-plus licensing deal for recombinant antibody for oncology
Articles
| 3 min read
By
Jim Cirigliano
An alternative to liver transplantation
Collaboration between University of Cambridge and GSK seeks a breakthrough in A1AT deficiency treatment
Articles
| 2 min read
By
Jim Cirigliano
Looking to build a bit of synergy
Synergy Pharmaceuticals to formally merge with Callisto Pharmaceuticals
Articles
| 3 min read
By
Jim Cirigliano
Calling the X-MAN to battle cancer gene
Horizon Discovery and Domainex to explore lead molecules against TBK1/IKKe
Articles
| 3 min read
By
Jim Cirigliano
Closing the circle on Huntington’s disease
Thomson Reuters to collaborate with the CHDI Foundation to develop new tools to battle Huntington’s disease
Articles
| 3 min read
By
Jim Cirigliano
CoMMpass to multiple myeloma treatment
MMRF and US Oncology Research collaborate on landmark clinical study to advance personalized treatments for incurable blood cancer
Articles
| 3 min read
By
Jim Cirigliano
Cold Spring Harbor Lab, Pfizer partner on cancer therapy research
Collaborators aim to create next-generation short-hairpin RNA library
Articles
| 3 min read
By
Jim Cirigliano
Breaking the Parkinson’s bottleneck
Berg Pharma partners with Parkinson’s Institute to identify biomarkers in Parkinson’s disease
Articles
Page 8 of 8 - 95 Total Items
1
2
3
4
5
6
7
8
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
Tell Us What You Know: Building robust chromatographic methods through inert hardware
Hear an expert perspective on the hidden variables affecting chromatographic methods and how to build more robust, reliable workflows.
Webinars
Explained: How can molecular biology teams scale therapeutic design with connected workflows?
To keep pace with modern drug discovery, researchers need molecular biology approaches that can support complexity without slowing down the science.
Explainers
How can labs become truly sustainable?
Creating more sustainable laboratories depends on practical changes that strengthen scientific performance while reducing environmental impact.
Video